0001209191-18-039730.txt : 20180627
0001209191-18-039730.hdr.sgml : 20180627
20180627200037
ACCESSION NUMBER: 0001209191-18-039730
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180625
FILED AS OF DATE: 20180627
DATE AS OF CHANGE: 20180627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pope Todd
CENTRAL INDEX KEY: 0001584367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 18922937
MAIL ADDRESS:
STREET 1: C/O TRANSENTERIX
STREET 2: 635 DAVIS DRIVE, SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-25
0
0000876378
TRANSENTERIX INC.
TRXC
0001584367
Pope Todd
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
1
1
0
0
President and CEO
Common Stock
2018-06-25
4
M
0
138555
0.35
A
454627
D
Common Stock
2018-06-25
4
S
0
100000
4.35
D
354627
D
Common Stock
2018-06-25
4
M
0
61445
0.35
A
416072
D
Common Stock
2018-06-25
4
S
0
100000
4.85
D
316072
D
Common Stock
2018-06-26
4
M
0
160086
0.35
A
476158
D
Common Stock
2018-06-26
4
S
0
160086
5.35
D
316072
D
Stock Option
0.35
2018-06-25
4
M
0
138555
0.00
D
2015-03-02
2022-04-12
Common Stock
138555
0
D
Stock Option
0.35
2018-06-25
4
M
0
61445
0.00
D
2013-06-02
2022-04-12
Common Stock
61445
221258
D
Stock Option
0.35
2018-06-26
4
M
0
160086
0.00
D
2014-10-02
2022-04-12
Common Stock
160086
61172
D
The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017.
Following the sales on June 25, 2018 and June 26, 2018, the reporting person continues to beneficially own 316,072 shares of the company's common stock. The reporting person also holds stock options to acquire 4,035,262 shares of common stock, of which approximately 47% are vested, and restricted stock units representing an additional 2,226,555 shares of common stock subject to forfeiture restrictions.
/s/ Joshua Weingard, as Attorney-in-Fact for Todd Pope
2018-06-27